Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 3 - The Untold Story

MarketBeat's Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky

Netflix and Meta Platforms lead recent analyst downgrades yet retain bullish consensus ratings, while Lululemon faces a Reduce rating amid fundamental brand and growth concerns.

MarketBeat · Sep 15

Could Dave & Buster’s Capitulation Signal the Bottom Is Finally In?

Dave & Buster's stock hit a record low after weak Q2 results, but positive free cash flow, improving comps, and analyst price targets suggest deep value and a potential bottom.

MarketBeat · Sep 15

Navan's Strong Quarter Meets an AI Spending Reality Check

Navan shares fell over 15% despite strong Q2 revenue growth and raised guidance, as investors weigh rising AI-related costs and the newly acquired BoomPop events platform.

MarketBeat · Sep 15

From analysis to the latest developments in health,
read the most diverse news in one place.

LightPath’s Defense Pivot Could Send Shares Higher

LightPath Technologies posted 73% YOY revenue growth and a swelling backlog as it pivots to defense optics, earning a Moderate Buy consensus despite wider net losses.

MarketBeat · Sep 15

3 Dividend Kings to Buy While They’re Still Beaten Down

Target, Hormel and Procter & Gamble, all Dividend Kings, are rebounding from depressed valuations with reliable yields, improving traffic or market share trends, and firming analyst support.

MarketBeat · Sep 14

Intel’s Price Hikes Could Put $120 Back in Play

Intel shares rallied on unconfirmed reports of a 10% CPU price hike amid tight server chip supply, prompting analyst upgrades even as MarketBeat's consensus rating remains a Hold.

MarketBeat · Sep 14

3 Small-Cap Biotechs With Binary Catalysts on the Calendar

Kodiak Sciences, Capricor Therapeutics and Invivyd each face pivotal clinical trial or FDA decisions before the end of 2026 that could significantly move their stock prices.

MarketBeat · Sep 13

Read news from The Economist, FT, and more,
with one subscription

Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound

Planet Labs shares have fallen more than 60% from 2026 highs despite strong Q2 revenue growth, and analysts' $32.78 consensus price target implies over 90% upside potential.

MarketBeat · Sep 13

Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers

Phillips 66, Valero, and Marathon Petroleum posted strong earnings beats as widening crack spreads from higher oil prices lifted refiner stocks past current analyst price targets.

MarketBeat · Sep 12

American Eagle Goes on Sale: Is It Time to Buy?

American Eagle shares fell after Q2 results despite record revenue, but tariff refunds, growth at Aerie and OFFLINE, a 3% dividend yield, and analyst targets suggest upside potential.

MarketBeat · Sep 12

MarketBeat Week in Review – 09/07 - 09/11

Stocks fell this week on oil prices and Fed rate-hike expectations, though Oracle's earnings underscored AI infrastructure strength. MarketBeat analysts recap top stories on earnings, defense, AI, and other stock opportunities.

MarketBeat · Sep 12

Amgen Drops 10% on a Trial It Didn't Even Run

AMGN stock fell after Novartis' Pelacarsen trial failed, though Amgen's own Olpasiran and Repatha differ in mechanism and results, and analysts have kept price targets largely intact.

MarketBeat · Sep 11

Oracle’s AI Spending Is Still Huge, But the Payoff Is Starting to Show in Earnings

Oracle's fiscal Q1 revenue grew nearly 30% with a record $23 billion cash flow and surging backlog, as analysts cite an AI monetization inflection point supporting a Moderate Buy consensus.

MarketBeat · Sep 11

Microsoft’s Azure Reporting Shift Adds Clarity, But the Bull Case Came First

Microsoft is restructuring into two segments and will disclose quarterly Azure revenue starting fiscal 2027, but analyst ratings and price targets show the stock's rally predates the filing.

MarketBeat · Sep 11

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat · Sep 10

AeroVironment's Record Backlog and Earnings Beat Fuel Recovery Case

AeroVironment posted a Q1 revenue and earnings beat with record backlog, prompting Moderate Buy ratings from analysts and price targets implying significant upside from current levels.

MarketBeat · Sep 10

Insider Sales Eclipse $450M Across 3 AI Winners, With NVIDIA Leading the Pack

NVIDIA, Caterpillar, and Elastic insiders sold over $450 million in shares combined after strong rallies, led by NVIDIA's Mark Stevens, Caterpillar's CEO Joseph Creed, and Elastic's Shay Banon.

MarketBeat · Sep 10

GameStop’s Comeback Case Is Getting Interesting, But eBay Still Looks Stronger

GameStop's Q2 revenue fell nearly 20% as software and hardware sales slumped, though Collectibles grew 57%. Analysts favor eBay, GameStop's cleaner, more profitable holding, over GME shares.

MarketBeat · Sep 10

Why Braze’s Guidance Miss May Be a Gift for Investors

Braze shares fell after soft Q3 guidance, but strong Q2 revenue growth, rising net retention, and increased analyst price targets suggest the pullback may be a buying opportunity.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat · Sep 10

Palantir's New U.S. Army Contract Brings It Closer to Owning the Full Battlefield System

Palantir won a $127 million production contract as prime contractor for the Army's TITAN ground stations, expanding its defense role even as PLTR shares pulled back after August's rally.

MarketBeat · Sep 9

Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer

Casey's General Stores shares fell after Q1 FY2027 results despite revenue and earnings growth, as analysts maintain Moderate Buy ratings and a $928.53 price target implying notable upside.

MarketBeat · Sep 9

Cathie Wood Trimmed Palantir, But the Bigger Story Is Still Valuation

Cathie Wood's ARK trimmed its Palantir stake by about $25 million amid a broader portfolio rotation, but strong commercial growth, government contracts, and a Moderate Buy rating suggest the stock's rally may continue.

MarketBeat · Sep 8

Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected

Tesla's muted Cybercab launch and a new federal safety probe into its steering-wheel-free design sent shares lower, raising questions about the robotaxi's path to becoming a scalable business.

MarketBeat · Sep 8

Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock

Broadcom fell after earnings despite strong AI chip demand, but analysts remain bullish as investors weigh near-term guidance, TPU share and supply limits.

MarketBeat · Sep 8

Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement

After Meta settled its youth social media lawsuit for up to $18 billion, Morgan Stanley expects a wave of new AI products and maintains a $775 price target on the stock.

MarketBeat · Sep 8

Short Sellers Are Betting Against 3 AI Infrastructure Stocks—What Could Turn the Tide?

Super Micro Computer, CoreWeave, and IREN all carry heavy short interest as investors weigh rapid AI infrastructure growth against margin, cash flow, and spending concerns.

1 2 3 4 5

Coverage From

MarketBeat

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations